Stem Cell Company TheraVitae Establishes Subsidiary In North America

Published: Jul 12, 2006

07/12/2006 - TheraVitae, an international biotechnology company, the producer of VesCell(TM) a cellular therapy for heart disease and developer of additional adult stem cell technologies for incurable disorders completed a North American license agreement with TheraVitae Inc., which establishes TheraVitae Inc. as an exclusive licensee of North America. In parallel with the closing of the agreement, TheraVitae Inc. completed a $3,000,000 non-brokered private placement.

Back to news